Featured Research

from universities, journals, and other organizations

Delayed pediatric appendicitis treatment linked to complications, and even death

Date:
October 15, 2011
Source:
American Academy of Pediatrics
Summary:
An in-hospital delay of appendicitis treatment beyond two days was linked to an increased likelihood of complications, including perforation and abscess formation; longer hospitalization; increased costs; and more rarely, death, according new research.

An in-hospital delay of appendicitis treatment beyond two days was linked to an increased likelihood of complications, including perforation and abscess formation; longer hospitalization; increased costs; and more rarely, death, according an abstract presented on Oct. 15 at the American Academy of Pediatrics (AAP) National Conference and Exhibition in Boston.

In "Missed Opportunities in the Treatment of Pediatric Appendicitis," researchers reviewed National Inpatient Sample (NIS) data on nearly 800,000 appendectomies, the most common inpatient surgical procedure in children. The study identified 17,737 children under age 18 who experienced delayed treatment, with a mean time interval from hospital arrival to appendectomy of 4.5 days.

These children had an increased perforated appendicitis (22.6 percent compared to an 18.9 percent rate for children receiving more immediate treatment) and a 20-fold increase in mortality -- 0.68 percent versus 0.03 percent. Mean hospital stays for the delayed treatment group were more than 10 days compared to 2.89 days; and total cost was $54,172 versus nearly $18,000 for children treated within two days of hospital admission.

"An in-hospital delay of two days was associated with a significant increase in complicated appendicitis requiring more extensive procedures," said Justin Lee, MD, lead author of the study. The increase in procedures included a 13-fold increase in drainage procedures, a 6-fold increase in cecectomies and 14-fold increase in hemicolectomies -- both surgeries to remove a portion of a child's colon.

The risks are especially acute for children living with other diseases.

"Another very important finding is the higher incidence of co-morbid diseases in the delayed treatment group," said Dr. Lee. Children with acute lymphoblastic leukemia, acute myelogenous leukemia, neutropenia and ovarian cyst without torsion were more likely to receive treatment two days after hospitalization.

"These specific comorbid conditions may suggest that there is a high-risk group of patients who may present with more advanced stages of disease or missed diagnosis during hospitalization," Dr. Lee said. "Future systemic approaches to early identification of those at highest risk may decrease in-hospital delay, while also reducing economic burden of complicated appendicitis and surgical complications."


Story Source:

The above story is based on materials provided by American Academy of Pediatrics. Note: Materials may be edited for content and length.


Cite This Page:

American Academy of Pediatrics. "Delayed pediatric appendicitis treatment linked to complications, and even death." ScienceDaily. ScienceDaily, 15 October 2011. <www.sciencedaily.com/releases/2011/10/111015094015.htm>.
American Academy of Pediatrics. (2011, October 15). Delayed pediatric appendicitis treatment linked to complications, and even death. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/10/111015094015.htm
American Academy of Pediatrics. "Delayed pediatric appendicitis treatment linked to complications, and even death." ScienceDaily. www.sciencedaily.com/releases/2011/10/111015094015.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins